USPTO serial 85282398
VINCERINONE
Reviewed by CopyMark Law Group
Reg. 4332375Status 710
- Filing date
- Status date
- Registration date
- May 7, 2013
- Examiner
- MILTON, PRISCILLA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with VINCERINONE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
BIOELECTRON TECHNOLOGY CORPORATION
MOUNTAIN VIEW, CA
Other trademarks owned by BIOELECTRON TECHNOLOGY CORPORATION
Mountain View, CA
Mountain View, CA
Mountain View, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Carla B. Oakley
Carla B. Oakley Morgan, Lewis & Bockius, LLPOne Market Street, Spear Street TowerSan Francisco, CA 94105UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medicinal products and preparations to treat and optimize mitochondrial function; pharmaceutical and medicinal products and preparations to treat and suppress disorders involving inherited defective mitochondria; pharmaceutical and medicinal products and preparations to treat and suppress diseases involving acquired mitochondrial dysfunction; pharmaceutical and medicinal products and preparations to treat and optimize conditions that alter energy metabolism; pharmaceutical and medicinal products and preparations to treat and suppress neurodegenerative diseases; pharmaceutical and medicinal products and preparations to treat and suppress neurological disorders; pharmaceutical and medicinal products and preparations to treat and suppress pervasive developmental disorders; pharmaceutical and medicinal products and preparations to treat and suppress ophthalmic disorders; pharmaceutical and medicinal products and preparations to treat and suppress hearing disorders | SECTION 8 - CANCELLED | Nov 19, 2012 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIOELECTRON TECHNOLOGY CORPORATION
- Other trademarks owned by Edison Pharmaceuticals, Inc.
- Other trademarks owned by Edison Pharmaceuticals, Inc.
- Other trademarks owned by Edison Pharmaceuticals, Inc.
- Other trademarks in Class 005
- Similar marks named VINCERINONE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 13, 2019 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| May 7, 2018 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 8, 2017 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Feb 10, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 10, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 7, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 3, 2013 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED | — |
| Apr 2, 2013 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Apr 2, 2013 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 13, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 12, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 12, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 25, 2013 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 25, 2013 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 21, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 14, 2013 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Feb 13, 2013 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Feb 7, 2013 | IUAF | USE AMENDMENT FILED | — |
| Feb 7, 2013 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Oct 12, 2012 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Oct 11, 2012 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 10, 2012 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 9, 2012 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 9, 2012 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 11, 2012 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Apr 9, 2012 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 9, 2012 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 9, 2012 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 11, 2011 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 16, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 27, 2011 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 12, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 6, 2011 | ALIE | ASSIGNED TO LIE | — |
| Jul 5, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 27, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 5, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 4, 2011 | NWAP | NEW APPLICATION ENTERED | — |